Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00374738
Other study ID # NC181BO-1 (IRB #01012)
Secondary ID DUHS Protocol No
Status Completed
Phase N/A
First received September 7, 2006
Last updated February 27, 2009
Start date November 2006
Est. completion date September 2008

Study information

Verified date February 2009
Source Samueli Institute for Information Biology
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Our specific aims are:

1. To examine the efficacy of GIFT in improving MST-related clinical outcomes in women veterans

2. To examine the effects of GIFT on fronto-limbic brain function and

3. To examine the effects of GIFT on levels of neuroactive steroid associated with PTSD.


Description:

Guided imagery is a complementary and alternative treatment (CAM) modality. This directed meditation technique uses healing imagery to promote recovery in a variety of illnesses, including cancer, heart disease and, more recently, posttraumatic stress disorder (PTSD). PTSD is a severe and disabling anxiety disorder. It is among the most common mental disorders, affecting 10% of women in the United States during their lifetime. Sexual assault is the most common cause of PTSD. Similarly, military sexual trauma (MST) is disturbingly common among women in the armed forces. At least 20% of women veterans using VA services report a history of sexual assault. Unfortunately, high rates of MST-related PTSD are anticipated among women currently deployed to Iraq and Afghanistan.

To address this issue, we will evaluate a guided imagery intervention for women veterans who have MST-related PTSD. We will evaluate the efficacy of Guided Imagery for Trauma (GIFT) in decreasing PTSD symptoms. Using brain-imaging techniques, this research will examine the effects of GIFT on brain function in the areas associated with PTSD. We will also examine the effects of GIFT on neurosteroids, which are candidate modulators of PTSD symptoms, and may also represent novel targets for therapeutic intervention.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date September 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Aged 18-65

- Status as a woman veteran

- Receives care at the Durham VAMC

- History of MST

- DSM-IV diagnosis of PTSD, confirmed by CAPS interview

- Able to participate in a research interview in English

- Regular telephone access

Exclusion Criteria:

- Current diagnosis of organic or psychotic mental disorder

- Suicidality or parasuicidality

- Ongoing family violence

- Alcohol or drug dependence within previous 3 months

- Enrolled in cognitive-behavioral/exposure-based therapy during study period.

- Supportive therapy and psychiatric medications (if stabilized at least 3 months prior to enrollment) are acceptable.

- An uncontrolled medical condition

Exclusion Criteria for the fMRI only:

- Foreign metallic objects or implanted devices in the body incompatible with MRI

- Positive pregnancy test as determined by serum ß-HCG level

- Claustrophobia

- CNS neoplasms or neurological conditions such as Parkinson's Disease, Huntington's Chorea, demyelinating diseases, seizures, hydrocephalus, etc.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Guided Imagery for Trauma (GIFT)


Locations

Country Name City State
United States Women Veterans' Comprehensive Health Center (WVCHC) @ Durham Veterans Affairs Medical Center (DVAMC) Durham North Carolina

Sponsors (3)

Lead Sponsor Collaborator
Samueli Institute for Information Biology Duke University, Durham VA Medical Center

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT01636791 - CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care Phase 3
Completed NCT00870545 - Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study N/A
Completed NCT01459705 - Comparing Virtual Reality Exposure Therapy to Prolonged Exposure N/A
Completed NCT00099983 - Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder Phase 2
Active, not recruiting NCT01216982 - Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders Phase 2
Not yet recruiting NCT00320437 - Intergenerational Transmission of Terror Phase 1
Completed NCT00974402 - Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings N/A
Completed NCT01717547 - Strength and Awareness in Action N/A
Terminated NCT01062022 - FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured N/A
Completed NCT01565213 - Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care Phase 3
Recruiting NCT01538082 - Role of the Stress in the Development of the Metabolic Syndrome N/A
Completed NCT01667822 - Cognitive Behavioral Therapy, Guided Self Help Versus Individual Therapy Phase 3
Completed NCT01667809 - CBT vs RTW Intervention for Patients With Common Subclinical Mental Illness in Primary Care Phase 3
Completed NCT01277354 - Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication N/A